A device for treating tissue may include a tissue expander configured to be inserted into a body lumen and stretch tissue surrounding the body lumen, and a tool configured to be coupled to the tissue expander and move along a path defined by the tissue expander.
|
1. A device for treating tissue, comprising:
a tissue expander configured to be inserted into a body lumen and stretch tissue surrounding the body lumen; and
a tool configured to be coupled to the tissue expander and move along a path defined by the tissue expander, wherein the tissue expander includes a first support ring and a second support ring, wherein the path is defined at a first end by the first support ring and at a second end by the second support ring, and wherein the tool is configured to move relative to the first support ring and the second support ring along the path.
19. A device for treating tissue, comprising:
a tissue expander configured to be inserted into a body lumen and stretch tissue surrounding the body lumen, wherein the tissue expander includes:
a first support ring, wherein the first support ring includes a first mating feature disposed on at least one of a proximally-facing surface or a distally-facing surface of the first support ring; and
a second support ring, wherein the second support ring includes a first mating feature disposed on at least one of a proximally-facing surface or a distally-facing surface of the second support ring; and
a tool configured to be coupled to the tissue expander and move along a path defined by the tissue expander, wherein the tool includes:
a first attachment portion configured to be coupled to the first support ring, the first attachment portion including a second mating feature that is complementary to the first mating feature of the first support ring, and
a second attachment portion configured to be coupled to the second support ring, the second attachment portion including a second mating feature that is complementary to the first mating feature of the second support ring.
17. A device for treating tissue, comprising:
a tissue expander configured to be inserted into a body lumen and stretch tissue surrounding the body lumen, wherein the tissue expander includes:
a first support ring including a first mating feature disposed on at least one of a proximally-facing surface or a distally-facing surface of the first support ring; and
a second support ring including a first mating feature disposed on at least one of a proximally-facing surface or a distally-facing surface of the second support ring;
a tool configured to be coupled to the tissue expander and move along a path defined by the tissue expander; wherein:
the path is defined at a first end by the first support ring and at a second end by the second support ring;
the tool is configured to move circumferentially along the path;
the tool includes a first attachment portion configured to be coupled to the first support ring, the first attachment portion including a second mating feature that is complementary to the first mating feature of the first support ring; and
the tool includes a second attachment portion configured to be coupled to the second support ring, the second attachment portion including a second mating feature that is complementary to the first mating feature of the second support ring;
one or more spacers disposed between the first support ring and the second support ring, wherein:
the one or more spacers are longitudinally expandable; and
a length of the tool between the first attachment portion and the second attachment portion is equal to a length of the one or more spacers.
3. The device of
4. The device of
5. The device of
6. The device of
7. The device of
8. The device of
9. The device of
10. The device of
12. The device of
13. The device of
14. The device of
16. The device of
18. The device of
20. The device of
|
This patent application claims the benefit under 35 U.S.C. § 119 to U.S. Provisional Patent Application No. 62/269,556, filed on Dec. 18, 2015, the entirety of which is incorporated herein by reference.
Examples of the present disclosure relate to resection tools and related methods of use.
Colorectal cancer is a leading cause of death in the United States. One treatment option for the removal of malignant and pre-malignant lesions is endoscopic mucosal or en bloc resection. Resections can allow for the pathological determination of tissue health.
In order to remove the tissue, the surgeon often carefully cuts through the mucosa and submucosa, a process which is time consuming and difficult as the tissue easily deforms and deflects when pressure is applied. Other challenges include difficulty in locating the submucosal layer, maintaining an adequate lift height for a duration long enough to perform the resection, difficulty injecting the lifting solution through conventional injection needles, and repeatedly exchanging devices through an endoscope.
In one aspect, the present disclosure is directed to a medical device. The device may include a tissue expander configured to be inserted into a body lumen and lift tissue surrounding the body lumen, and a tool configured to be coupled to the tissue expander and move along a path defined by the tissue expander.
The tissue expander may include a first support ring and a second support ring, wherein the path may be defined at a first end by the first support ring and at a second end by the second support ring, and wherein the tool may be configured to move circumferentially along the path. The device may include one or more spacers disposed between the first support ring and the second support ring, wherein the one or more spacers may be longitudinally expandable. The tool may include a first attachment portion configured to be coupled to the first support ring, and a second attachment portion configured to be coupled to the second support ring, wherein a length of the tool between the first attachment portion and the second attachment portion may be equal to a length of the one or more spacers. The first attachment portion may include a first mating feature, the second attachment portion may include a first mating feature, the first support ring may include a second mating feature disposed on at least one of a proximally-facing surface and a distally-facing surface, and the second support ring may include a second mating feature disposed on at least one of a proximally-facing surface and a distally-facing surface, wherein the first mating feature of the first attachment portion may be complementary to the second mating feature of the first support ring, and wherein the first mating feature of the second attachment portion may be complementary to the second mating feature of the second support ring. One of the first mating feature and the second mating feature may be a recess, and the other of the first mating feature and the second mating feature may be a pin, bearing, ball, protrusion, wheel, or roller configured to be received by the recess. The tool may include a cutting member extending radially outward when the tool is coupled to the tissue expander. The tissue expander may include anchoring features extending radially outward from an outer circumferential surface.
In another aspect, the present disclosure is directed to a medical device. The device may include a first support, and a plurality of leg assemblies coupled to the first support, wherein the plurality of leg assemblies may be circumferentially arranged about a central longitudinal axis of the device, wherein at least one pair of adjacent leg assemblies may be separated from one another by a first angle defined in a plane that is normal to the central longitudinal axis of the device, and wherein remaining pairs of adjacent leg assemblies may be separated from one another by second angles defined in the plane that are less than the first angle. Each of the plurality of leg assemblies may include a first pivot joint connecting a corresponding leg assembly to the first support; a first leg extending from the first pivot joint, the first leg being configured to pivot relative to the first support via the first pivot joint, a second pivot joint disposed at a distal end of the first leg, and a second leg extending distally from the second pivot joint, the second leg being configured to pivot relative to the first leg via the second pivot joint.
Distal ends of each of the second legs may be unconnected to one another, the first angle may be from 80 degrees to 120 degrees, and each of the second angles may be from 20 degrees to 60 degrees. The first leg and the second leg of each of the plurality of leg assemblies may be substantially parallel to the central longitudinal axis when the device is in a collapsed configuration. The device may be movable to an expanded configuration, wherein in the expanded configuration, the first leg of each of the plurality of leg assemblies may be transverse to the central longitudinal axis, and the second leg of each of the plurality of leg assemblies may be substantially parallel to the central longitudinal axis. The device may further include a second support disposed proximally of the first support, and a plurality of linkages extending from the second support, wherein at least one linkage of the plurality of linkages may be coupled to each first leg of the plurality of leg assemblies, wherein, when a proximal force is applied to the second support, the second support may move proximally relative to the first support to cause the linkages to pull proximally on each first leg of the plurality of leg assemblies, causing each first leg to pivot proximally via its respective first pivot joint, and moving the device to the expanded configuration. The first support and the second support ring each may include a lumen, and wherein the lumens of the first support and the second support may be aligned to enable the passage of an endoscope through the lumens. Each first pivot joint may include a locking mechanism configured to limit a proximal retraction of a respective first leg.
In yet another aspect, the present disclosure is directed to a method of manipulating tissue. The method may include stretching tissue with a tissue expander to define body lumen, positioning a tool relative to the tissue expander, and moving the tool along a path defined by the tissue expander.
The tissue expander may include a first support ring and a second support ring, wherein the path defined by the tissue expander may be a circumferential path defined at a first end by the first support ring, and at a second end by the second support ring. The method may include, before the using step, positioning the second support ring distal to a targeted treatment area, and positioning the first support ring proximal to the targeted treatment area, wherein the stretched tissue may include the targeted treatment area disposed between the first support ring and the second support ring. The tool may include a cutting member, and moving the tool along the path defined by the tissue expander may remove a portion of the stretched tissue defining the body lumen. The body lumen may be located within a colon.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various examples and together with the description, serve to explain the principles of the disclosed examples.
Reference will now be made in detail to examples of the present disclosure, which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts or components. The term “distal” refers to the direction that is away from the user or operator and into the patient's body. By contrast, the term “proximal” refers to the direction that is closer to the user or operator and away from the patient's body.
In at least some examples, the present disclosure is directed to systems, devices, and methods used to facilitate endomucosal or en bloc resection of colorectal or other tissues. Some components of the system may be used to stretch and hold tissue walls (e.g., the colorectal wall) in a regular cylindrical shape or other suitable shape for resection of tissue. Other components of the system may help perform the actual resection by slicing and/or removing tissue.
A tissue expander 100 is shown in
Referring to
Second support 104 may be substantially similar to first support 102, or may include one or more different features. First support 102 and second support 104 may be arranged such that only proximally-facing surface 106 of first support 102 includes mating features 110, while only the distally-facing surface 108 of second support 104 includes mating features 110. In other examples, the proximal-facing surface 106 and the distally-facing surface 108 of both first support 102 and second support 104 may include mating features 110.
Referring to
One or more spacers 116 may be disposed between first support 102 and second support 104. The spacers 116 may extend longitudinally between the first support 102 and the second support 104. The spacers 116 may be formed of a shape memory material that it is set or pre-shaped into a straight and linear expanded configuration as shown in
In another example, spacers 116 may not be formed from a shape memory material, but may instead be formed of a different biocompatible material. For example, spacers 116 may be stiff and linear linkages. In another example, spacers 116 may be manually actuated by a screw mechanism or other similar mechanical mechanism to achieve a desired distance between first support 102 and second support 104 in vivo. In one example, each spacer 116 and only one of the supports 102 or 104 may be threaded. The non-threaded support may be fixed to each spacer in such a way that the spacer is allowed to rotate but not travel longitudinally. In the initial configuration, each spacer may extend beyond the threaded support. By actuating the spacer clockwise or counter-clockwise, the threaded support may travel longitudinally along the spacer until a limit is reached. In another example, each support may have spacer that connect to a hub. The two hubs may be threaded with opposite twists and connected by a single threaded actuator with a matching twist on each half. When the actuator is rotated clockwise or counter-clockwise, the hubs may move closer together or father apart, forcing the supports connected by the spacers to move accordingly until a limit is reached. The spacing could be manually actuated or could be actuated by a piezoelectric motor or array of motors controlled by an ex vivo driver. In another example, the distance between the support rings may be controlled by a zip-tie.
Spacers 116 may be attached to first support 102 and second support 104 at circumferentially spaced locations to enable a removal tool 300 (described below) to translate along a circumferential path disposed between adjacent spacers 116. The spacers 116 may be biased longitudinally outwardly to cause first support 102 and second support 104 to separate. In the example shown in
Spacers 116 may also include an undulating shape to allow for lengthening and/or compression to change the distance between two support rings and to increase the scaffolding area. The spacers 116 may also have a configuration in which they bow in or out, exposing a larger surface area and/or offering additional support between the support rings.
Referring to
A removal tool 300 is shown in
Tool 300 also may include a cutting member 314 that extends radially outward from side surface 306. The cutting member 314 may be any suitable surgical cutting tool, such as, e.g., a knife, blade, edge, or the like. Cutting member 314 may include one or more other geometric features such as, e.g., serrations, teeth, tapers, bevels or the like to further facilitate spearing, cutting, or slicing of cutting member 314 through tissue. Cutting member 314 may have a cutting surface 330 that extends from side surface 306 at a first end 332 and at a second end 334. At least a portion of the cutting surface 330 may be spaced apart from the side surface 306. In the example shown in
Removal tool 300 may be coupled to a controller 316, which may include a processor that is generally configured to accept information from the system and system components, and process the information according to various algorithms to produce control signals for controlling cutting member 314. The processor may accept information from the system and system components, including various temperature, impedance, or other sensors, and process the information according to various algorithms. The processor may be a digital IC processor, analog processor, or any other suitable logic or control system that carries out the control algorithms. Controller 316 may include or may be otherwise coupled to a suitable power source (e.g., RF, laser, HIFU). Controller 316 also may be configured to control the degree to which cutting member 314 extends from side surface 306, or may otherwise control the depth of tissue through which cutting member 314 may penetrate. In some examples, the depth of cutting member 314 may be controlled manually.
Removal tool 300 may be coupled to an actuator 318 configured to move the removal tool 300 along a circumferential path around a body lumen, using first support 102 and/or second support 104 as guides. Actuator 318 may be any suitable mechanism, and may include mechanical linkages manually operated by a user, or may include a motor operated by a controller, such as, e.g., controller 316. Actuator 318 may be configured to move removal tool 300 in a first circumferential direction and a second circumferential direction that opposes the first circumferential direction. In one example, the operator could control the removal tool 300 by use of the endoscope and there may be no actuator 318 present. Actuator 318 may also be an array of piezoelectric motors that interface with the support rings 102 and 104 and are driven ex vivo by a controller.
Tissue expander 100 may be movable from a collapsed configuration shown in
Referring to
Tissue expander 100 may be delivered to a body lumen 410 by elongate member 400 or by another suitable delivery system. Body lumen 410 may be a lumen of the colon, although other suitable body lumens are also contemplated. Body lumen 410 may be defined by a tissue wall 412, which may include an irregular topology or surface represented in the Figures by a plurality of longitudinally spaced ridges 414 (or other irregularities in tissue) that may extend radially inward from an inner circumference of the tissue wall 412 into the body lumen 410.
Distal end 404 may be positioned distally of target tissue 416 (which may be cancerous or potentially-cancerous tissue desired to be resected) as shown in
First support 102 and second support 104 may be coupled to one another by flexible spacers 116 while disposed within elongate member 400. However, in other examples, first support 102 and second support 104 may be uncoupled to one another while disposed within elongate member 400, and may be inserted separately into the body lumen 410. In such examples, a user may position second support 104 distally of target tissue 416, and subsequently position first support 102 proximally of target tissue 416. Once first support 102 and second support 104 are expanded by the mechanisms set forth above, one or more spacers 116 may be inserted between first support 102 and second support 104. Spacers 116 then may be expanded until a desired distance is achieved between first support 102 and second support 104, which may be when, for example, the surface of tissue wall 412 becomes substantially cylindrical, or when first support 102 and second support 104 are separated from each other by a distance approximately equal to the length of the removal tool 300 between attachment portions 308.
Once the first support 102 and second support 104 are spaced apart from one another by a desired distance (that, e.g., corresponds to the distance between attachment portions 308), removal tool 300 may be inserted into body lumen 410 via, e.g., elongate member 400 or another suitable delivery member, and may be coupled with first support 102 and second support 104 as shown in
In some examples, one or more of spacers 116 may be removed or repositioned before cutting member 314 is used to remove tissue from tissue wall 412. That is, because removal tool 300 and cutting member 314 travel circumferentially about the body lumen via first support 102 and second support 104, the presence of spacers 116 along the circumference of the first support 102 and second support 104 may interfere with the removal of target tissue by blocking the path of removal tool 300 along the track provided by mating features 110. In some examples, all of spacers 116 may be removed from the body lumen 410 before or after removal tool 300 is positioned into the body lumen 410. In one example, all of the spacers 116 may be removed, and first support 102 and second support 104 may be configured to retain their position relative to one another by one or more surface features or anchoring features 118. In another example, only those spacers 116 necessary to clear a circumferential path for removal tool 300 may be removed. Spacers 116 also may be repositioned to create a circumferential path for removal tool 300 around body lumen 410. That is, spacers 116 may be configured to be moved along a circumferential path created by first support 102 and second support 104. In such examples, spacers 116 may be slid along a track of mating feature 110 from a first circumferential position to a second circumferential position if access of the removal tool 300 to the targeted tissue 416 is blocked when a spacer 116 is disposed in the first circumferential position.
The en bloc resected tissue may be removed from body lumen 410 by conventional mechanisms, such as, e.g., graspers, suction, or the like. Bleeding may be controlled using conventional methods after the resection is complete. The removal tool 300 then may be removed, followed by first support 102, second support 104, and spacers 116 (if not already removed).
In at least some examples of the present disclosure, the need to visualize a cut and submucosa during the procedure may be eliminated because the cut depth may be controlled by the cutting member 314. The need to inject saline or similar solutions to raise the target tissue or tumor also may be eliminated. In some examples of the present disclosure, this may result in fewer or no through-the-scope device exchanges being performed. The risk of damage to the muscularis also may be reduced because of the increased control of the cutting depth.
A tissue expander 800 is shown in
A plurality of leg assemblies 808 may extend distally from the support 806. Seven leg assemblies 808a-g are shown in the example of
Joints 812 and 816 may be pivotable joints such as, e.g., a ball and socket joint, a pivot joint, a swivel joint, or another suitable pivotable joint. Joint 812 may include a locking mechanism configured to limit the proximal retraction of first legs 810. In some examples, the locking mechanism of joint 812 may prevent the first legs 810 from being retracted proximally of support 806. While first leg 810 is in the expanded configuration, an angle Θ (shown in perspective in
In the collapsed configuration, the entirety of each leg assembly 808 may be substantially parallel to a central longitudinal axis 822 of the tissue expander 100. That is, the first leg 810 and the second leg 814 of each leg assembly 808 may be substantially parallel to the central longitudinal axis 822 of tissue expander 800 while in the collapsed configuration. As seen in
Referring to
In the expanded configuration, each first leg 810 may be radially offset from center longitudinal axis 822 by 15 degrees to 90 degrees, and each first leg 810 may be offset form center longitudinal axis 822 by the same amount as every other first leg 810. Because each first leg 810 may be radially offset from the central longitudinal axis 822 at an angle Θ, the distance between central longitudinal axis 822 and leg 810 may increase linearly in the distal direction while tissue expander 800 is in the expanded configuration.
Referring to
The tissue expander 800 may be positioned at a distal end of a scope via, e.g., support 806. Once the tissue expander 800 is in the expanded configuration, an operator may detach the tissue expander 800 from the scope, allowing the scope to move freely within the body lumen to, e.g., perform the cutting or other functions necessary for a resection. This arrangement may improve the visibility and use of tools through the working channel of the scope. The tissue expander 800 may remain tethered to the scope to allow for easy removal of both the scope and the tissue expander 800 once the procedure is completed.
In an alternative example, one or more of first leg 810 and second leg 814 may be formed of a shape memory material, such as, e.g., nitinol. In this alternative example, joints 812 and 816 may not be pivotable joints, but may instead be bends in a continuous piece of the shape memory material. In this example, the tissue expander 800 may be pre-bent into the expanded configuration as shown in
Tissue expander 800 may be positioned in a body lumen of a patient while disposed in the collapsed configuration, and while support 806 is attached to the distal end of an endoscope. Once a target area desired to be resected is identified, the scope and tissue expander 800 may be manipulated to place gap 820 adjacent to the target area. Once gap 820 is adjacent the target area, a proximal force may be applied to actuating members 828, causing support 826 to retract proximally relative to support 806. This may cause the first legs 810 of the plurality of leg assemblies 808 to pivot proximally, which in turn may cause the tissue expander 800 to move from the collapsed configuration of
As used herein, two objects and/or references (e.g., axes, planes, or the like) may be “substantially parallel” to one another if they are parallel to one another, are offset from one another by less than 1 degree, by less than 5 degrees, or by less than 10 degrees, as dictated by, e.g., machining imperfections and the like.
Those skilled in the art will understand that the medical devices set out above can be implemented in any suitable body lumen (e.g., blood vessels, the biliary tract, urological tract, gastrointestinal lumens, and the like) without departing from the scope of the disclosure as defined by the claims. In particular, constructional details, including manufacturing techniques and materials, are well within the understanding of those of skill in the art and have not been set out in any detail here. These and other modifications and variations are well within the scope of the present disclosure and can be envisioned and implemented by those of skill in the art.
Other examples of the present disclosure will be apparent to those skilled in the art from consideration of the specification and practice of the examples disclosed herein. It is intended that the specification and examples be considered as exemplary only, and departures in form and detail may be made without departing from the scope and spirit of the present disclosure as defined by the following claims.
Gregorich, Daniel J., Huot, Adam, Braun, Johnathan J., Merkling, Selina M., Robertson, Kimberly Anne, Frost, Matthew Nelson
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
8506479, | Dec 16 2009 | LUMENR, LLC ; Boston Scientific Scimed, Inc | Substantially rigid and stable endoluminal surgical suite for treating a gastrointestinal lesion |
20040210116, | |||
20120095498, | |||
20130110109, | |||
20140012192, | |||
20140379012, | |||
20150045616, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Dec 15 2016 | MARTIN, KEVIN | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Dec 15 2016 | WITTROCK, JONATHAN PATRICK | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Dec 15 2016 | GREGORICH, DANIEL J | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Dec 15 2016 | ROBERTSON, KIMBERLY ANNE | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Dec 16 2016 | BRAUN, JOHNATHAN J | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Dec 16 2016 | Boston Scientific Scimed, Inc. | (assignment on the face of the patent) | / | |||
Mar 23 2017 | HUOT, ADAM | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Mar 24 2017 | MILLER, LAURA FINN | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Apr 05 2017 | FROST, MATTHEW NELSON | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Apr 05 2017 | BENNETT, RYAN S | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
Apr 11 2017 | RUBESCH, TIMOTHY LAWRENCE | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
May 18 2017 | TILLMAN, COREY | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 | |
May 23 2017 | MERKLING, SELINA M | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042516 | /0592 |
Date | Maintenance Fee Events |
Jul 24 2023 | REM: Maintenance Fee Reminder Mailed. |
Jan 08 2024 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Dec 03 2022 | 4 years fee payment window open |
Jun 03 2023 | 6 months grace period start (w surcharge) |
Dec 03 2023 | patent expiry (for year 4) |
Dec 03 2025 | 2 years to revive unintentionally abandoned end. (for year 4) |
Dec 03 2026 | 8 years fee payment window open |
Jun 03 2027 | 6 months grace period start (w surcharge) |
Dec 03 2027 | patent expiry (for year 8) |
Dec 03 2029 | 2 years to revive unintentionally abandoned end. (for year 8) |
Dec 03 2030 | 12 years fee payment window open |
Jun 03 2031 | 6 months grace period start (w surcharge) |
Dec 03 2031 | patent expiry (for year 12) |
Dec 03 2033 | 2 years to revive unintentionally abandoned end. (for year 12) |